Cessation

July 24, 2026 To To The Manager, Listing Department The General Manager, Listing Department National Stock Exchange of India Limited BSE Limited Plot no. C/1 G Block, Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (East), Dalal Street, Mumbai- 400 051 Mumbai- 400 001 Symbol: BLISSGVS Scrip Code: 506197 Subject: Intimation of Resignation of Mr Sachin Saboo, General Manager – Regulatory & Clinical (Senior Management Personnel) of the Company Dear Sir/Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations") read with Part A of Schedule III to the said regulations, we hereby inform you that Mr. Sachin Saboo, General Manager – Regulatory and Clinical and a Senior Management Personnel (‘SMP’) of the Company, has resigned from the services of the Company vide his letter dated April 30, 2026, citing his intent to move forward in a direction that aligns more closely with his professional aspirations. The Company has accepted his resignation and relieved him from the duties of the Company with effect from close of business hours on July 24, 2026. The said resignation letter is enclosed herewith. Details required under Regulation 30 of the Listing Regulations, read with applicable SEBI Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, are enclosed herewith as ‘Annexure A’. Kindly take the above intimation on record. Yours faithfully, For Bliss GVS Pharma Limited Aditi Bhatt Company Secretary Encl: As above “Annexure – A” Details pursuant to Regulation 30 of SEBI Listing Regulations, read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 No. Particulars Details i. Name of Senior Management Personnel Mr. Sachin Saboo, General Manager – Regulatory and Clinical ii. Reason for Change viz. appointment, Resignation citing his intent to move resignation, removal, death or otherwise forward in a direction that aligns more closely with his professional aspirations. iii. Date of Appointment/Cessation July 24, 2026 iv. Brief Profile Not Applicable v. Disclosure of relationships between Not Applicable directors